New Investment From Orzaks Medicine

Orzaks Medicine became a partner with Palmiye Medicine that one of the reliable company of the sector. Orzaks Medicine will share its knowledge and experience with Palmiye Medicine and contribute to its development by supporting it financially. Orzaks Medicine is continuing its rapid growth in the OTC sector purchased 75% of Palmiye Medicine, which has been operating in the sector since 2005. Palmiye Medicine include Dr. Thomson, Carlson, Sunlife, Formoline L112, Samberry, Bialabor, Okyanosea in the brand.

With this partnership, Palmiye Medicine is targeted to be among the top 10 companies operating in the pharmacy channel in 2023. Orzaks Medicine in addition to food supplements with new investments that is also aims to focus on dermocosmetic, medical and pharmaceutical fields.